Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

This study has been completed.
Sponsor:
Collaborator:
Innovacell Biotechnologie AG
Information provided by:
University Medical Centre Ljubljana
ClinicalTrials.gov Identifier:
NCT01355133
First received: May 12, 2011
Last updated: May 16, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
No publications provided by University Medical Centre Ljubljana

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):